RZLT

Rezolute (RZLT)

Rezolute Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RZLT

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	05:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/06/15	05:49	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RZLT	Rezolute Inc
2024/06/15	01:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/06/14	12:30	GlobeNewswire Inc.	Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants	NASDAQ:RZLT	Rezolute Inc
2024/06/14	06:25	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RZLT	Rezolute Inc
2024/06/14	05:01	GlobeNewswire Inc.	Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:RZLT	Rezolute Inc
2024/05/30	21:00	GlobeNewswire Inc.	Rezolute to Participate in the Jefferies Global Healthcare Conference	NASDAQ:RZLT	Rezolute Inc
2024/05/29	03:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/05/25	03:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/05/22	05:05	GlobeNewswire Inc.	Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)	NASDAQ:RZLT	Rezolute Inc
2024/05/18	05:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/05/16	05:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RZLT	Rezolute Inc
2024/05/16	05:05	GlobeNewswire Inc.	Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update	NASDAQ:RZLT	Rezolute Inc
2024/04/23	21:00	GlobeNewswire Inc.	Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting	NASDAQ:RZLT	Rezolute Inc
2024/03/12	06:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/03/11	23:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/03/06	21:30	GlobeNewswire Inc.	Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)	NASDAQ:RZLT	Rezolute Inc
2024/02/27	22:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/02/23	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/02/22	01:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/02/14	07:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RZLT	Rezolute Inc
2024/02/14	06:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RZLT	Rezolute Inc
2024/02/14	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/02/14	06:05	GlobeNewswire Inc.	Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update	NASDAQ:RZLT	Rezolute Inc
2024/01/30	07:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/26	02:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
2024/01/24	22:00	GlobeNewswire Inc.	Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer	NASDAQ:RZLT	Rezolute Inc